RTSN
Retension Pharmaceuticals Inc · NASDAQ:RTSN
11.36 USD−0.4700 −3.97%
Retension Pharmaceuticals Inc (NASDAQ:RTSN) last traded at 11.36 USD, down 3.97% on the day. Over the past year the stock is up 13.60%. Its 52-week range is 9.66 to 18.64. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open11.76
Day range10.85 – 11.76
52-week range9.66 – 18.64
Volume58.85 K
Average volume (10 days)96.97 K
Market cap94.65 M
Dividend yield0.00%
Beta (1 year)−28.12
Performance
−28.33%1 week
+13.60%1 month
+13.60%3 months
+13.60%6 months
+13.60%Year to date
+13.60%1 year
Technical reading
Strongly bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Retension Pharmaceuticals Price Target Announced at $55.00/Share by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim initiates coverage of Retension Pharmaceuticals at Buy, sets price target at $55TradingView · 02 Nov 2026
- Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessionalSeeking Alpha · 30 Oct 2026
- Retension Pharmaceuticals appoints Robert Wong as chief accounting officerTradingView · 23 Oct 2026
- Eric Keller Discloses Investment at Retension Pharmaceuticals with 7.07% StakeTradingView · 14 Oct 2026
- Retension Pharmaceuticals Shares Slide in Trading Debut After IPODow Jones Newswires · 09 Oct 2026
- Retension Pharmaceuticals prices upsized IPO at $12 per shareSeeking Alpha · 09 Oct 2026
- Retension Pharmaceuticals Announces Pricing of Initial Public OfferingGlobeNewswire · 09 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.